EMDA®+MMC to plug BCG shortage
BAUS, EAU and NICE have suggested that hospitals switch to our EMDA®+Mitomycin-C treatment due to the worldwide shortage of BCG.
Physion Appoints JS Consulting in MENA
Physion has appointed JS Consulting as their strategic advisor for the GCC & Middle East regions.
NICE Updates Guidance for EMDA®
NICE has called for EMDA® to be used in research programmes as a treatment for bladder cancer.